Cloning Technology: Control the Bonanza for Research Eggs
By Marcy Darnovsky, Susan Berke Fogel, Judy Norsigian,
Nature
| 12. 01. 2011
[Letter to the editor]
The demand for women’s eggs for research could soar alarmingly following news of a cloning technique that uses human oocytes to reprogram somatic cells to a state of pluripotency (S. Noggle et al. Nature 478, 70–75; 2011).
The mean number of eggs given by each woman during the study was 16.9, with one donating 26 eggs. This is more than many fertility doctors would consider optimal and increases the risk of ovarian hyperstimulation syndrome. The researchers do not say that they halted hormone treatment in cases of over-response, although they did stop it in under-responsive women.
Noggle et al. rightly anticipated concerns that payment for eggs could encourage financially disadvantaged women to take risks they might otherwise avoid. But US$8,000, the amount paid by Noggle and colleagues, would be a temptation even to the well-off in these difficult economic times.
Some argue that women should evaluate for themselves the risks and benefits of providing eggs for research. But informed consent depends on provision of accurate information. Even after years of egg harvesting for fertility treatment, the risks to women —...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...